Browsing Tag
Reckitt Benckiser
6 posts
HLN share price firms as Sensodyne and Centrum drive Haleon’s 2026 organic growth recovery
Sensodyne grows 8%. Centrum targets GLP-1 users. The £500m buyback erases shares at sub-340p. Haleon's recovery hinges on Q2 cold and flu normalising.
Reckitt Benckiser (LSE: RKT) holds FY2026 guidance at +4-5% despite Q1 cold season drag and Europe weakness
Reckitt Benckiser holds 2026 guidance at +4-5% LFL after Q1 shows 3.1% ex-seasonal growth. Emerging Markets surge but Europe drags. Read our analysis.
Reckitt Benckiser set to offload £6bn homecare business in sweeping overhaul
Reckitt Benckiser Group plc, the global consumer goods company, is making waves in the market with its plans…
Reckitt Benckiser to sell 92% stake in Chinese infant formula business for $1.3bn
Reckitt Benckiser Group has agreed to divest 92% stake in Infant Formula and Child Nutrition business in China…
Reckitt Benckiser to acquire Biofreeze pain relief brand from Performance Health
Reckitt Benckiser Group (RB) has agreed to acquire the Biofreeze topical pain relief brand from Madison Dearborn Partners…
Pfizer faces setback as Reckitt Benckiser and GSK withdraw from $20bn consumer health deal
Pfizer’s $20 Billion Sale Stalls: In a significant turn of events in the pharmaceutical industry, both Reckitt Benckiser…